HK1130496A1 - 3'-ethynylcytidine derivative 3'- - Google Patents

3'-ethynylcytidine derivative 3'-

Info

Publication number
HK1130496A1
HK1130496A1 HK09108626.6A HK09108626A HK1130496A1 HK 1130496 A1 HK1130496 A1 HK 1130496A1 HK 09108626 A HK09108626 A HK 09108626A HK 1130496 A1 HK1130496 A1 HK 1130496A1
Authority
HK
Hong Kong
Prior art keywords
substituted
group
hydrogen atom
represented
ethynylcytidine derivative
Prior art date
Application number
HK09108626.6A
Other languages
English (en)
Inventor
Motoaki Tanaka
Masakazu Fukushima
Original Assignee
Taiho Pharmaceutical Co Ltd
Takuma Sasaki
Matsuda Akira
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd, Takuma Sasaki, Matsuda Akira filed Critical Taiho Pharmaceutical Co Ltd
Publication of HK1130496A1 publication Critical patent/HK1130496A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
HK09108626.6A 2006-07-24 2009-09-21 3'-ethynylcytidine derivative 3'- HK1130496A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006200587 2006-07-24
PCT/JP2007/000787 WO2008012945A1 (fr) 2006-07-24 2007-07-23 Dérivé de 3'-éthynylcytidine

Publications (1)

Publication Number Publication Date
HK1130496A1 true HK1130496A1 (en) 2009-12-31

Family

ID=38981261

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09108626.6A HK1130496A1 (en) 2006-07-24 2009-09-21 3'-ethynylcytidine derivative 3'-

Country Status (15)

Country Link
US (1) US8058261B2 (xx)
EP (1) EP2045258B1 (xx)
JP (1) JP4989649B2 (xx)
KR (1) KR101426101B1 (xx)
CN (1) CN101490076B (xx)
AT (1) ATE525386T1 (xx)
AU (1) AU2007278000B2 (xx)
BR (1) BRPI0714705A2 (xx)
CA (1) CA2658917C (xx)
HK (1) HK1130496A1 (xx)
MX (1) MX2009001003A (xx)
NZ (1) NZ574362A (xx)
RU (1) RU2441876C2 (xx)
TW (1) TWI449528B (xx)
WO (1) WO2008012945A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102219817A (zh) * 2011-04-12 2011-10-19 连云港杰瑞药业有限公司 活性偶联剂用于氟化嘧啶化合物烷氧羰酰化的方法
SG11201608538UA (en) * 2014-04-29 2016-11-29 Biosearch Technologies Inc Compounds compositions and methods including thermally labile moieties
WO2018230479A1 (ja) * 2017-06-13 2018-12-20 大原薬品工業株式会社 ヌクレオシド系抗がん剤又は抗ウィルス剤の5'位シリルエーテル誘導体
CN115536710B (zh) * 2022-10-18 2024-04-16 南京工业大学 一种高品质胞苷硫酸盐晶体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77133A (en) 1984-12-04 1991-01-31 Lilly Co Eli Antineoplastic pharmaceutical compositions containing pentofuranoside derivatives,some new such compounds and their preparation
ZA859008B (en) * 1984-12-04 1987-07-29 Lilly Co Eli The treatment of tumors in mammals
RU2130029C1 (ru) * 1994-12-13 1999-05-10 Тайхо Фармасьютикал Ко., Лтд. 3'-замещенные производные нуклеозида, способ их получения (варианты), лекарственное средство, способ лечения и профилактики
JP3792005B2 (ja) 1997-04-24 2006-06-28 彰 松田 2−デオキシ−3−エチニル−β−D−リボフラノシル誘導体

Also Published As

Publication number Publication date
CA2658917C (en) 2014-10-21
TWI449528B (zh) 2014-08-21
RU2441876C2 (ru) 2012-02-10
MX2009001003A (es) 2009-02-06
EP2045258A1 (en) 2009-04-08
BRPI0714705A2 (pt) 2013-05-14
CN101490076B (zh) 2012-05-30
ATE525386T1 (de) 2011-10-15
TW200817014A (en) 2008-04-16
US20090306008A1 (en) 2009-12-10
KR101426101B1 (ko) 2014-08-13
CA2658917A1 (en) 2008-01-31
NZ574362A (en) 2010-10-29
AU2007278000B2 (en) 2011-12-15
US8058261B2 (en) 2011-11-15
EP2045258A4 (en) 2010-10-06
JP4989649B2 (ja) 2012-08-01
CN101490076A (zh) 2009-07-22
KR20090033875A (ko) 2009-04-06
EP2045258B1 (en) 2011-09-21
RU2009106034A (ru) 2010-08-27
AU2007278000A1 (en) 2008-01-31
WO2008012945A1 (fr) 2008-01-31
JPWO2008012945A1 (ja) 2009-12-17

Similar Documents

Publication Publication Date Title
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
EP1775289A4 (en) NEW IMIDAZOLIDINE DERIVATIVES
HK1139381A1 (en) Bicyclic -amino acid derivative
MX2009010071A (es) Derivados de aril isoxazolina insecticidas.
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
MY144971A (en) Prodrug of cinnamide compound
TW200745034A (en) New compounds
EP1795536A4 (en) PHOSPHORAMIDITE COMPOUND AND PROCESS FOR THE PREPARATION OF OLIGO RNA
MX2009010024A (es) Nuevo compuesto de adenina.
EP1679309A4 (en) ANTISTRESS MEDICAMENT AND ITS MEDICAL USE
DK1628685T3 (da) Antivirale phosphonatanaloge
MD20110063A2 (en) Herbicidal compositions containing benzoylpyrazole compounds
MY149180A (en) Uracil compound having inhibitor activity on human deoxyuridine triphosphatase or salt thereof
WO2008108380A3 (en) Pyrrole compounds
TW200738684A (en) Novel sulfated cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
WO2011004162A3 (en) 1, 2, 4-thiazolidin-3-one derivatives and their use in the treatment of cancer
ATE360045T1 (de) Polycarbonatzusammensetzungen
MX2010001566A (es) Derivado de aminopirazolamida.
TW200637870A (en) Novel pyrimidine nucleoside compound and salt thereof
HK1130496A1 (en) 3'-ethynylcytidine derivative 3'-
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
DK2000473T3 (da) Trehalose-forbindelse og lægemiddel omfattende forbindelsen
TW200745048A (en) Novel benzimidazole and benzothiazole derivatives, preparation process therefor, application thereof as medicaments, pharmaceutical compositions and novel use especially as CMET inhibitors
WO2009057733A1 (ja) 血管新生阻害活性を有する新規インドール誘導体
NO20053997D0 (no) Oligosaccharidderivat

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160723